Background: In accordance with the scientific literature heavy alcohol consumption
(>50g per day) represents a risk factor for several diseases development, including cancer. However,
the oncogenic role of light alcohol drinking (<12.5g per day) is still unknown.
Objective: To assess the scientific knowledge about light alcohol consumption and the risk of malignancy
Methods: To collect the scientific evidences regarding this topic the keywords “light alcohol drinking”,
“light alcohol consumption” and “cancer”, were used. Papers published during the last 15
years were analyzed, in order to select the most recent evidence. Meta-analyses with well-defined
levels of alcohol intake were included in the present review. Other studies that focused on biochemical,
molecular and genetic aspects, as well as duplicate articles, were excluded.
Results: Twenty-nine large, meta-analyses were included in this review. Light alcohol drinking
was not associated with an increased risk of cancer occurrence, with the exception of breast and
prostate cancer and melanoma.
Furthermore, a possible protective role of light alcohol consumption on the development of bladder,
kidney and ovarian cancer and Non Hodgkin Lymphoma was observed.
Conclusion: Light alcohol drinking was not associated with the development of several malignancies,
except for a light increase of melanoma, breast cancer in women and prostate cancer in men.